A single course or 2 consecutive omalizumab courses are associated with long-term chronic spontaneous urticaria remission (4 years) in about 50% of patients. Planned discontinuation of omalizumab may lead to considerable cost savings and avoid unnecessary drug exposure for patients.
Duration of chronic spontaneous urticaria remission after omalizumab discontinuation: A long-term observational study
Di Bona D.;Minenna E.;Albanesi M.;Macchia L.
2021-01-01
Abstract
A single course or 2 consecutive omalizumab courses are associated with long-term chronic spontaneous urticaria remission (4 years) in about 50% of patients. Planned discontinuation of omalizumab may lead to considerable cost savings and avoid unnecessary drug exposure for patients.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
